Immune Therapeutics, Inc. Stock Agreements
3 Contracts & Agreements
- Amendment to the Articles of Incorporation filed March 12, 2020 approving an increase in authorized shares of common stock from 500,000,000 to 750,000,000 (Filed With SEC on August 14, 2020)
- Amendment to the Articles of Incorporation filed February 5, 2020 approving a reverse split of issued and outstanding shares of common stock by 1,000 to 1 (Filed With SEC on August 14, 2020)
- Stock Agreement (Filed With SEC on June 11, 2018)
